Amazon Web Services unveiled Amazon Bio Discovery, an AI‑powered suite that lets researchers design, test and refine drug candidates in weeks instead of months. The platform links more than 40 specialized models with a lab‑in‑the‑loop workflow, letting scientists send top molecules to partner labs for synthesis and receive real‑time feedback. Early adopters such as Memorial Sloan Kettering Cancer Center, Bayer and the Broad Institute report dramatic cuts in development timelines, while AWS promises to keep scientists in the loop rather than replace them. Read more →